Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramiconazole oral solution for pityriasis versicolor
2005-004852-11Phase 2Completed
- Sponsor
- Barrier Therapeutics, Inc.
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of pramiconazole in pityriasis versicolor (6 arms), sponsored by Barrier Therapeutics, Inc. Primary endpoint: Effective Treatment at Day 28. Started Dec 2005; status: completed.
02
Drugs
pramiconazole
03
Conditions
pityriasis versicolor
Beyond the preview
Go deeper on 2005-004852-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004852-11.